CIK 0001660334
- Non-accelerated filer
- Smaller reporting company
Verrica Pharmaceuticals Inc.
Sign in to watch- Ticker
- VRCA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 463137900
- Phone
- +1 484-453-3300
- Business address
- 44 WEST GAY STREET, SUITE 400, WEST CHESTER, PA
- 4 Open-market buy Director bought 4,126,142 shares at $4.24 ($17,505,157)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Open-market sale CHIEF LEGAL OFFICER sold 4,315 shares at $0.65 ($2,805)
- 4/A Grant or award Chief Medical Officer acquired 50,000 shares (grant or award)
- 4/A Grant or award CHIEF FINANCIAL OFFICER acquired 125,000 shares (grant or award)
- 4/A Grant or award CHIEF LEGAL OFFICER acquired 150,000 shares (grant or award)
- 4/A Grant or award PRESIDENT AND CEO acquired 150,000 shares (grant or award)
- 4/A Grant or award CHIEF COMMERCIAL OFFICER acquired 125,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy CEO and President bought 280,898 shares
- 4 Open-market buy Director bought 1,123,595 shares
Page 2 of 13 · 253 filings